Clinical Trial: Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358520) titled 'Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients' on Jan. 14.

Brief Summary: This study is a prospective, multicenter, parallel-controlled clinical trial designed to evaluate the therapeutic efficacy of Huaier Granules for proteinuria occurring in lung cancer patients undergoing treatment with either Bevacizumab or Anlotinib.

Study Start Date: Jan. 28

Study Type: INTERVENTIONAL

Condition: Proteinuria

Intervention: DRUG: Huaier Granule

Take orally, 10g each time, three times daily.

DRUG: Anlotinib and Bevacizumab

Administer according to...